Literature DB >> 15749732

Expression of membrane-bound IL-15 by bone marrow fibroblast-like stromal cells in aplastic anemia.

Li Wenxin1, Fu Jinxiang, Wang Yong, Li Wenxiang, Shi Wenbiao, Zhang Xueguang.   

Abstract

In order to explore the relationship between IL-15 and aplastic anemia (AA), bone marrow (BM) fibroblast-like stromal cells (BMFSCs) were obtained from BM samples of 23 AA patients by density centrifugation and primary culturing in vitro. Indirect immunofluorescence labeling as well as flow cytometry and confocal laser scanning microscopy analysis were used to determine the expression of membrane-bound IL-15 (mIL-15) on the surface of BMFSCs derived from AA patients (AA-BMFSCs). The effects of IFN-gamma and cyclosporin A (CsA) on the expression of mIL-15 were also investigated. [(3)H]thymidine incorporation test as well as specific antibody inhibition and Transwell separation experiment was adopted to functionally evaluate the expression of mIL-15 on the surface of AA-BMFSCs. mIL-15 was found to be over-expressed on the surface of AA-BMFSCs. IFN-gamma further significantly up-regulated its expression, which, however, was inhibited by CsA. Interestingly, a tight correlation was found between the expression of mIL-15 and IL-15Ralpha on the surface of AA-BMFSCs. AA-BMFSCs had the capability to stimulate the proliferation of T lymphocytes, which was partly or completely inhibited by using neutralizing anti-IL-15Ralpha antibody, neutralizing anti-IL-15 antibody, blocking anti-IL-2/15Rgamma(c) mAb or Transwell chambers with a 0.3-mum pore size membrane to block the direct cell-to-cell contact between AA-BMFSCs and T cells. Apparently, BMFSCs as the most important component of BM hematopoietic microenvironment usually over-express mIL-15 in AA patients. Therefore, AA-BMFSCs may indirectly participate in the T cell-mediated destruction of hematopoietic progenitors in AA by recruiting T cells to BM and stimulating them in situ.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15749732     DOI: 10.1093/intimm/dxh223

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  7 in total

1.  Gamma interferon suppresses erythropoiesis via interleukin-15.

Authors:  Isis K Mullarky; Frank M Szaba; Lawrence W Kummer; Lindsey B Wilhelm; Michelle A Parent; Lawrence L Johnson; Stephen T Smiley
Journal:  Infect Immun       Date:  2007-02-16       Impact factor: 3.441

2.  Safety and immunologic effects of IL-15 administration in nonhuman primates.

Authors:  Carolina Berger; Michael Berger; Robert C Hackman; Michael Gough; Carole Elliott; Michael C Jensen; Stanley R Riddell
Journal:  Blood       Date:  2009-07-15       Impact factor: 22.113

3.  Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease.

Authors:  Clara Bueno; Mar Roldan; Eduardo Anguita; Damia Romero-Moya; Beatriz Martín-Antonio; Michael Rosu-Myles; Consuelo del Cañizo; Francisco Campos; Regina García; Maite Gómez-Casares; Jose Luis Fuster; Manuel Jurado; Mario Delgado; Pablo Menendez
Journal:  Haematologica       Date:  2014-04-11       Impact factor: 9.941

4.  Neutrophil-endothelial interactions mediate angiopoietin-2-associated pulmonary endothelial cell dysfunction in indirect acute lung injury in mice.

Authors:  Joanne Lomas-Neira; Fabienne Venet; Chun-Shiang Chung; Rajan Thakkar; Daithi Heffernan; Alfred Ayala
Journal:  Am J Respir Cell Mol Biol       Date:  2014-01       Impact factor: 6.914

Review 5.  Bone Marrow Failure Syndromes, Overlapping Diseases with a Common Cytokine Signature.

Authors:  Valentina Giudice; Chiara Cardamone; Massimo Triggiani; Carmine Selleri
Journal:  Int J Mol Sci       Date:  2021-01-12       Impact factor: 5.923

6.  IL-15 expression on RA synovial fibroblasts promotes B cell survival.

Authors:  Marta Benito-Miguel; Yolanda García-Carmona; Alejandro Balsa; María-Belén Bautista-Caro; Irene Arroyo-Villa; Tatiana Cobo-Ibáñez; María Gema Bonilla-Hernán; Carlos Pérez de Ayala; Paloma Sánchez-Mateos; Emilio Martín-Mola; María-Eugenia Miranda-Carús
Journal:  PLoS One       Date:  2012-07-09       Impact factor: 3.240

Review 7.  Mesenchymal Stem Cell Benefits Observed in Bone Marrow Failure and Acquired Aplastic Anemia.

Authors:  Vivian Fonseca Gonzaga; Cristiane Valverde Wenceslau; Gustavo Sabino Lisboa; Eduardo Osório Frare; Irina Kerkis
Journal:  Stem Cells Int       Date:  2017-12-03       Impact factor: 5.443

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.